Get started
Author

Cyrille Dreyfus

Observed name: C. Dreyfus
ORCID: 0009-0007-2979-0885
Observed ORCID: 0009-0007-2979-0885
OpenAlex ID: A5077720723
New World Bats Harbor Diverse Influenza A Viruses
2013 · Suxiang Tong, Xueyong Zhu, et al. · PLoS Pathogens · 1,413
PDF
Highly Conserved Protective Epitopes on Influenza B Viruses
2012 · Cyrille Dreyfus, Nick S. Laursen, et al. · Science · 860
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
2011 · Sarel J. Fleishman, Timothy A. Whitehead, et al. · Science · 595
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 · Timothy A Whitehead, Aaron Chevalier, et al. · Nature Biotechnology · 372
Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
2013 · Cyrille Dreyfus, Damian C. Ekiert, et al. · Journal of Virology · 111
A Novel Online Four-Dimensional SEC×SEC-IM×MS Methodology for Characterization of Monoclonal Antibody Size Variants
2018 · Anthony Ehkirch, Alexandre Goyon, et al. · Analytical Chemistry · 77
Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a V H 3-30-Encoded Heterosubtypic Antibody
2014 · Arkadiusz Wyrzucki, Cyrille Dreyfus, et al. · Journal of Virology · 68
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
2024 · Laura Carretero-Iglesia, Olivia J. Hall, et al. · Nature Cancer · 58
Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors
2019 · Barbara Akla, Matthieu Broussas, et al. · Molecular Cancer Therapeutics · 32
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
2024 · C. Grandclément, C. Estoppey, et al. · Nature Communications · 23
PDF
ISB 2001, a First-in-Class Trispecific BCMA and CD38 T Cell Engager Designed to Overcome Mechanisms of Escape from Treatments for Multiple Myeloma By Targeting Two Antigens
2022 · Maria Pihlgren, Olivia Hall, et al. · Blood · 16
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity
2025 · Jeremy Loyau, Thierry Monney, et al. · mAbs · 4
PDF
Abstract 815: New approach for old target: W0101 antibody drug conjugate effectively inhibits tumor growth in preclinical models of IGF-1R overexpressing solid tumors
2018 · Barbara Akla, Noureddine Loukili, et al. · Cancer Research · 3
Vers un vaccin universel contre la grippe ?
2013 · Cyrille Dreyfus · médecine/sciences · 3
PDF
Integrated Preclinical Data Analysis of ISB 2001 Enables Optimal Starting Dose Selection for a First-in-Class Trispecific T Cell Engager Phase1 Study in Multiple Myeloma
2023 · Adam Drake, Maria Pihlgren, et al. · Blood · 2
PDF
Abstract 2970: Overcoming mechanisms of escape from treatments for multiple myeloma with ISB 2001, a potential first-in-class trispecific BCMA and CD38 targeted T cell engager
2023 · Maria Pihlgren, Laura Carretero, et al. · Cancer Research · 1
Abstract 1238: ISB 2001, a BCMA and CD38 dual targeting T cell engager, demonstrates superior cytotoxicity relative to teclistamab in the samples of patient relapsing from CD38 and BCMA targeted immunotherapies
2024 · Laura Carretero-Iglesia, Maria Pihlgren, et al. · Cancer Research
Table S1, Table S2, Table S3, Table S4, Figure S1Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Figure S7 from Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors
2023 · Barbara Akla, Matthieu Broussas, et al.
Data from Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors
2023 · Barbara Akla, Matthieu Broussas, et al.
Data from Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors
2023 · Barbara Akla, Matthieu Broussas, et al.
Table S1, Table S2, Table S3, Table S4, Figure S1Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Figure S7 from Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors
2023 · Barbara Akla, Matthieu Broussas, et al.
Abstract 4054: Development of a new site-specific sulfomaleimide rebridging platform for the generation of homogeneous, stable, potent and safe antibody drug conjugates
2020 · Jean-Francois Haeuw, Frederic Marion, et al. · Cancer Research
Crystal structure of broadly neutralizing antibody CR9114 bound to H7 influenza hemagglutinin
2012 · D.C. Ekiert, C. Dreyfus, et al. · Worldwide Protein Data Bank
Influenza B HA Antibody (Fab) CR8033
2012 · C. Dreyfus, N.S. Laursen, et al. · Worldwide Protein Data Bank
Influenza B/Florida/4/2006 hemagglutinin Fab CR8071 complex
2012 · C. Dreyfus, N.S. Laursen, et al. · Worldwide Protein Data Bank
Works count: 27
Citation count: 3,638
H-index: 11
I10-index: 11
Year
Topic
Type